Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Genomic Biomarkers Global Market Report 2025
Download Free Sample Buy Now
Global Genomic Biomarkers Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Genomic Biomarkers Global Market Report 2025

By Type (Predictive Biomarkers, Prognostic Biomarkers), By Disease Indication (Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications), By Validation (Analytical Validation, Clinical Validation, Clinical Utility), By End-User (Hospitals, Diagnostic Centers, Other End User) – Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Genomic Biomarkers Market?

Genomic biomarkers are specific sequences or variations in DNA or RNA that provide information about a biological process, condition, or response to a particular treatment. These biomarkers are used in precision medicine to predict disease risk, diagnose conditions, monitor disease progression, or guide treatment decisions. Genomic biomarkers are crucial for personalized medicine, allowing healthcare providers to tailor treatments based on an individual's genetic makeup, improving the effectiveness of therapies, and reducing the likelihood of adverse effects.

The main types of genomic biomarkers are predictive biomarkers and prognostic biomarkers. Predictive biomarkers are biological molecules found in blood, other body fluids, or tissues that indicate whether a patient is likely to benefit from a particular medical treatment or intervention. The various disease indications include Oncology, cardiovascular diseases, neurological diseases, renal disorders, and others with various validation such as analytical validation, clinical validation, and clinical utility. These are used by various end-users such as hospitals, diagnostic centers, and others.

Genomic Biomarkers Market Size and growth rate 2025 to 2029: Graph

What Is The Genomic Biomarkers Market Size 2025 And Growth Rate?

The genomic biomarkers market size has grown rapidly in recent years. It will grow from $7.42 billion in 2024 to $8.72 billion in 2025 at a compound annual growth rate (CAGR) of 17.4%. The growth in the historic period can be attributed to the rising emphasis on various genetic testing activities, growing cases of chronic diseases, growing emphasis on precision medicine initiatives, growing adoption of companion diagnostics, and rising number of patients with neurological diseases.

What Is The Genomic Biomarkers Market Growth Forecast?

The genomic biomarkers market size is expected to see rapid growth in the next few years. It will grow to $16.51 billion in 2029 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to the increasing number of ovarian and gastric cancer cases, growing acceptance and awareness of genetic testing, increasing use of genomic biomarkers in cancer diagnosis and treatment, increasing number of cancer patients, and growing adoption of companion diagnostics. Major trends in the forecast period include next-generation sequencing (NGS), integration with other omics, genomic technological advancements, product innovations, and advanced healthcare services.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

How Is The Genomic Biomarkers Market Segmented?

The genomic biomarkersmarket covered in this report is segmented –

1) By Type: Predictive Biomarkers, Prognostic Biomarkers

2) By Disease Indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications

3) By Validation: Analytical Validation, Clinical Validation, Clinical Utility

4) By End-User: Hospitals, Diagnostic Centers, Other End User

Subsegments:

1) By Predictive Biomarkers: Drug Response Biomarkers, Companion Diagnostics Biomarkers, Pharmacodynamic Biomarkers, Predictive Genetic Markers for Disease Susceptibility

2) By Prognostic Biomarkers: Cancer Prognostic Biomarkers, Cardiovascular Disease Prognostic Biomarkers, Neurodegenerative Disease Prognostic Biomarkers, Infectious Disease Prognostic Biomarkers

What Is Driving The Genomic Biomarkers Market? Growth Of Genomic Biomarkers Market Driven By Personalized Medicine Demand

The increasing demand for personalized medicine is expected to propel the growth of the genomic biomarkers market going forward. Personalized medicine, also known as precision medicine, is a medical approach that tailors healthcare decisions and treatments to the individual characteristics of each patient, primarily based on their genetic and genomic information. The increasing demand for personalized medicine is due to several factors, such as the growing emphasis on patient-centered care, genetic sequencing and analysis advances, a patient-centric approach, and the use of EHRs to store and analyze patient data. Genomic biomarkers play a crucial role in personalized medicine by enabling healthcare providers to tailor medical treatments to an individual’s unique genetic makeup. This approach, also known as precision medicine, aims to optimize the effectiveness of treatments and minimize side effects by considering the genetic differences between individuals. For instance, in 2022, according to the Personalized Medicine Coalition, a US-based professional membership organization, 12 new customized medications were approved in 2022, accounting for around 34% of all newly approved treatments and a 34% increase over prior years. Therefore, the increasing demand for personalized medicine drives the growth of the genomic biomarkers market.

Who Are The Major Players In The Global Genomic Biomarkers Market?

Major companies operating in the genomic biomarkers market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Illumina Inc., PerkinElmer Inc., Almac Group, Azenta Inc., Novogene Corporation, Oxford Nanopore Technologies Ltd., Celerion, Quanterix Corporation, Bio-Rad Laboratories Inc., NantHealth Inc., Centogene N.V., Sophia Genetics SA, Envisagenics, Deep Genomics, Creative Diagnostics, Macrogen Inc., Guardant Health Inc., Sema4

What Are The Key Trends Of The Global Genomic Biomarkers Market? Advancements In Genomic Biomarkers To Enhance Precision Medicine In Lung Cancer

Major companies operating in the genomic biomarkers market are focused on developing innovative products, such as lung reagents, to enhance the detection of specific genetic mutations in lung cancer, improve diagnostic accuracy, and facilitate personalized treatment approaches by leveraging advanced genomic technologies. Lung reagents refer to specialized chemical or biological substances used in diagnostic tests, research, or medical procedures related to the lungs helping in precision medicine by guiding treatment choices based on the specific genetic profile of the cancer. For instance, in December 2023, Biofidelity, a UK-based company specializing in developing advanced genomic assays and precision diagnostics, launched ASPYRE-Lung reagents. The ASPYRE-Lung reagents are designed to identify key genetic mutations and alterations in lung cancer, which are critical for guiding targeted therapies and personalized treatment strategies.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Genomic Biomarkers Market? Biocare Medical Acquires Empire Genomics To Enhance Precision Diagnostics And Molecular Pathology Capabilities

In November 2022, Biocare Medical, a US-based company that manufactures immunohistochemistry (IHC) and molecular pathology products for cancer and infectious disease diagnostics, acquired Empire Genomics LLC for an undisclosed amount. The acquisition aims to strengthen Biocare Medical's precision diagnostics and molecular pathology capabilities. Empire Genomics LLC is a US-based company that manufactures genomic biomarkers for cancer diagnosis and personalized medicine.

What Is The Regional Outlook For The Global Genomic Biomarkers Market?

North America was the largest region in the genomic biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genomic biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Genomic Biomarkers Market?

The genomic biomarkers market consists of sales of genomic biomarker panels, real-time PCR detection systems, and droplet digital PCR (ddPCR) systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Genomic Biomarkers Industry?

The genomic biomarkers market research report is one of a series of new reports from The Business Research Company that provides genomic biomarkers market statistics, including genomic biomarkers industry global market size, regional shares, competitors with a genomic biomarkers market share, detailed genomic biomarkers market segments, market trends, and opportunities, and any further data you may need to thrive in the genomic biomarkers industry. This genomic biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Genomic Biomarkers Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $8.72 billion
Revenue Forecast In 2034 $16.51 billion
Growth Rate CAGR of 17.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Predictive Biomarkers, Prognostic Biomarkers
2) By Disease Indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications
3) By Validation: Analytical Validation, Clinical Validation, Clinical Utility
4) By End-User: Hospitals, Diagnostic Centers, Other End User Subsegments: 1) By Predictive Biomarkers: Drug Response Biomarkers, Companion Diagnostics Biomarkers, Pharmacodynamic Biomarkers, Predictive Genetic Markers for Disease Susceptibility
2) By Prognostic Biomarkers: Cancer Prognostic Biomarkers, Cardiovascular Disease Prognostic Biomarkers, Neurodegenerative Disease Prognostic Biomarkers, Infectious Disease Prognostic Biomarkers
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Illumina Inc., PerkinElmer Inc., Almac Group, Azenta Inc., Novogene Corporation, Oxford Nanopore Technologies Ltd., Celerion, Quanterix Corporation, Bio-Rad Laboratories Inc., NantHealth Inc., Centogene N.V., Sophia Genetics SA, Envisagenics, Deep Genomics, Creative Diagnostics, Macrogen Inc., Guardant Health Inc., Sema4
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Genomic Biomarkers Market Characteristics

3. Genomic Biomarkers Market Trends And Strategies

4. Genomic Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Genomic Biomarkers Growth Analysis And Strategic Analysis Framework

5.1. Global Genomic Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Genomic Biomarkers Market Growth Rate Analysis

5.4. Global Genomic Biomarkers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Genomic Biomarkers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Genomic Biomarkers Total Addressable Market (TAM)

6. Genomic Biomarkers Market Segmentation

6.1. Global Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Predictive Biomarkers

Prognostic Biomarkers

6.2. Global Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Cardiovascular Diseases

Neurological Diseases

Renal Disorders

Other Disease Indications

6.3. Global Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Analytical Validation

Clinical Validation

Clinical Utility

6.4. Global Genomic Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Diagnostic Centers

Other End User

6.5. Global Genomic Biomarkers Market, Sub-Segmentation Of Predictive Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Drug Response Biomarkers

Companion Diagnostics Biomarkers

Pharmacodynamic Biomarkers

Predictive Genetic Markers for Disease Susceptibility

6.6. Global Genomic Biomarkers Market, Sub-Segmentation Of Prognostic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cancer Prognostic Biomarkers

Cardiovascular Disease Prognostic Biomarkers

Neurodegenerative Disease Prognostic Biomarkers

Infectious Disease Prognostic Biomarkers

7. Genomic Biomarkers Market Regional And Country Analysis

7.1. Global Genomic Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Genomic Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genomic Biomarkers Market

8.1. Asia-Pacific Genomic Biomarkers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genomic Biomarkers Market

9.1. China Genomic Biomarkers Market Overview

9.2. China Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genomic Biomarkers Market

10.1. India Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genomic Biomarkers Market

11.1. Japan Genomic Biomarkers Market Overview

11.2. Japan Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genomic Biomarkers Market

12.1. Australia Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genomic Biomarkers Market

13.1. Indonesia Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genomic Biomarkers Market

14.1. South Korea Genomic Biomarkers Market Overview

14.2. South Korea Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genomic Biomarkers Market

15.1. Western Europe Genomic Biomarkers Market Overview

15.2. Western Europe Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genomic Biomarkers Market

16.1. UK Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genomic Biomarkers Market

17.1. Germany Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genomic Biomarkers Market

18.1. France Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genomic Biomarkers Market

19.1. Italy Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genomic Biomarkers Market

20.1. Spain Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genomic Biomarkers Market

21.1. Eastern Europe Genomic Biomarkers Market Overview

21.2. Eastern Europe Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genomic Biomarkers Market

22.1. Russia Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genomic Biomarkers Market

23.1. North America Genomic Biomarkers Market Overview

23.2. North America Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genomic Biomarkers Market

24.1. USA Genomic Biomarkers Market Overview

24.2. USA Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genomic Biomarkers Market

25.1. Canada Genomic Biomarkers Market Overview

25.2. Canada Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genomic Biomarkers Market

26.1. South America Genomic Biomarkers Market Overview

26.2. South America Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genomic Biomarkers Market

27.1. Brazil Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genomic Biomarkers Market

28.1. Middle East Genomic Biomarkers Market Overview

28.2. Middle East Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genomic Biomarkers Market

29.1. Africa Genomic Biomarkers Market Overview

29.2. Africa Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genomic Biomarkers Market Competitive Landscape And Company Profiles

30.1. Genomic Biomarkers Market Competitive Landscape

30.2. Genomic Biomarkers Market Company Profiles

30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Roche Diagnostics International Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Almac Group Overview, Products and Services, Strategy and Financial Analysis

31. Genomic Biomarkers Market Other Major And Innovative Companies

31.1. Azenta Inc.

31.2. Novogene Corporation

31.3. Oxford Nanopore Technologies Ltd.

31.4. Celerion

31.5. Quanterix Corporation

31.6. Bio-Rad Laboratories Inc.

31.7. NantHealth Inc.

31.8. Centogene N.V.

31.9. Sophia Genetics SA

31.10. Envisagenics

31.11. Deep Genomics

31.12. Creative Diagnostics

31.13. Macrogen Inc.

31.14. Guardant Health Inc.

31.15. Sema4

32. Global Genomic Biomarkers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genomic Biomarkers Market

34. Recent Developments In The Genomic Biomarkers Market

35. Genomic Biomarkers Market High Potential Countries, Segments and Strategies

35.1 Genomic Biomarkers Market In 2029 - Countries Offering Most New Opportunities

35.2 Genomic Biomarkers Market In 2029 - Segments Offering Most New Opportunities

35.3 Genomic Biomarkers Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Genomic Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Genomic Biomarkers Market, Sub-Segmentation Of Predictive Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Genomic Biomarkers Market, Sub-Segmentation Of Prognostic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Genomic Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Genomic Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Thermo Fisher Scientific Inc. Financial Performance
  • Table 78: Roche Diagnostics International Ltd. Financial Performance
  • Table 79: Illumina Inc. Financial Performance
  • Table 80: PerkinElmer Inc. Financial Performance
  • Table 81: Almac Group Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Genomic Biomarkers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Genomic Biomarkers Market, Sub-Segmentation Of Predictive Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Genomic Biomarkers Market, Sub-Segmentation Of Prognostic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Genomic Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Genomic Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Genomic Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Genomic Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Genomic Biomarkers Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 78: Roche Diagnostics International Ltd. Financial Performance
  • Figure 79: Illumina Inc. Financial Performance
  • Figure 80: PerkinElmer Inc. Financial Performance
  • Figure 81: Almac Group Financial Performance

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Genome Editing/Genome Engineering Global Market Report 2025 – By Product And Service( Reagents And Consumables, Software And systems, Services ), By Technology( CRISPR, TALEN, ZFN, Antisense, Other Technologies ), By App...

View Report

Single-Cell Genome Sequencing Global Market Report 2025 – By Type (Instruments, Reagents), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Quantitative Polymerase Chain Reaction (qPCR), ...

View Report

Whole Genome And Exome Sequencing Global Market Report 2025 – By Product Type (Kits, Instruments), By Workflow (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)), By Applications (Diagnostics, Cancer, Monogeni...

View Report

Digital Genome Global Market Report 2025 – By Type (Sequencing And Analyzer Instruments, Data Analysis And Management Tools), By Application (Diagnostics, Agriculture And Animal Research, Personalized Medicine, Drug Disc...

View Report

Biomarkers Global Market Report 2025 – By Technology (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers), By Disease (Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Dise...

View Report

Renal Biomarkers Global Market Report 2025 – By Biomarker Type (Functional Biomarker, Up Regulated Protein, Other Biomarker Types), By Diagnostic Technique (Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimet...

View Report

Non-Alcoholic Steatohepatitis Biomarkers Global Market Report 2025 – By Type (Hepatic Fibrosis Biomarkers, Serum Biomarkers, Oxidative Stress Biomarkers, Apoptosis Biomarkers, Other Types), By Disease (Hypertension, Hear...

View Report

Cardiac Biomarkers Testing Global Market Report 2025 – By Biomarkers Type (Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified albumin (IMA), Other Biomarkers Types)...

View Report

Frequently Asked Questions

Genomic biomarkers are specific sequences or variations in DNA or RNA that provide information about a biological process, condition, or response to a particular treatment. These biomarkers are used in precision medicine to predict disease risk, diagnose conditions, monitor disease progression, or guide treatment decisions. Genomic biomarkers are crucial for personalized medicine, allowing healthcare providers to tailor treatments based on an individual's genetic makeup, improving the effectiveness of therapies, and reducing the likelihood of adverse effects. For further insights on the Genomic Biomarkers market, request a sample here

The Genomic Biomarkers market major growth driver - Growth Of Genomic Biomarkers Market Driven By Personalized Medicine Demand. For further insights on the Genomic Biomarkers market, request a sample here

The Genomic Biomarkers market size has grown strongly in recent years. The genomic biomarkers market size has grown rapidly in recent years. It will grow from $7.42 $ billion in 2024 to $8.72 $ billion in 2025 at a compound annual growth rate (CAGR) of 17.4%. The growth in the historic period can be attributed to the rising emphasis on various genetic testing activities, growing cases of chronic diseases, growing emphasis on precision medicine initiatives, growing adoption of companion diagnostics, and rising number of patients with neurological diseases. The genomic biomarkers market size is expected to see rapid growth in the next few years. It will grow to $16.51 $ billion in 2029 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to the increasing number of ovarian and gastric cancer cases, growing acceptance and awareness of genetic testing, increasing use of genomic biomarkers in cancer diagnosis and treatment, increasing number of cancer patients, and growing adoption of companion diagnostics. Major trends in the forecast period include next-generation sequencing (NGS), integration with other omics, genomic technological advancements, product innovations, and advanced healthcare services. For further insights on the Genomic Biomarkers market, request a sample here

The genomic biomarkersmarket covered in this report is segmented –
1) By Type: Predictive Biomarkers, Prognostic Biomarkers
2) By Disease Indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications
3) By Validation: Analytical Validation, Clinical Validation, Clinical Utility
4) By End-User: Hospitals, Diagnostic Centers, Other End User
Subsegments:
1) By Predictive Biomarkers: Drug Response Biomarkers, Companion Diagnostics Biomarkers, Pharmacodynamic Biomarkers, Predictive Genetic Markers for Disease Susceptibility
2) By Prognostic Biomarkers: Cancer Prognostic Biomarkers, Cardiovascular Disease Prognostic Biomarkers, Neurodegenerative Disease Prognostic Biomarkers, Infectious Disease Prognostic Biomarkers For further insights on the Genomic Biomarkers market, request a sample here

North America was the largest region in the genomic biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Genomic Biomarkers market, request a sample here.

Major companies operating in the genomic biomarkers market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Illumina Inc., PerkinElmer Inc., Almac Group, Azenta Inc., Novogene Corporation, Oxford Nanopore Technologies Ltd., Celerion, Quanterix Corporation, Bio-Rad Laboratories Inc., NantHealth Inc., Centogene N.V., Sophia Genetics SA, Envisagenics, Deep Genomics, Creative Diagnostics, Macrogen Inc., Guardant Health Inc., Sema4 . For further insights on the Genomic Biomarkers market, request a sample here.

Major trends in the Genomic Biomarkers market include Advancements In Genomic Biomarkers To Enhance Precision Medicine In Lung Cancer. For further insights on the Genomic Biomarkers market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Genomic Biomarkers Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon